UroGen Announces FDA Acceptance of its New Drug Application for UGN-102

2 months ago

by David Miller

947 Views

Written by David Miller

PRINCETON, N.J.–(BUSINESS WIRE)–Oct. 15, 2024– UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced U.S. Food and Drug…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!